NeuroVasx appoints distributor for Japan:
This article was originally published in Clinica
Development-company NeuroVasx has appointed MDI Japan as distributor for its products there. The two companies hope to gain product registration in 1999. In November, NeuroVasx, of Plymouth, Minnesota, filed a 510(k) with the US FDA for its first product, the Sub-MicroInfusion catheter for the delivery of diagnostic agents to assess stroke. Separately, the US Patent and Trademark Office has allowed NeuroVasx a "substantial number of its claims" concerning its RPM macerator catheter. The product is used to combine the break-up of blood clots with the delivery of drugs for the treatment of acute stroke.
You may also be interested in...
The company will use the proceeds to fund clinical trials, expand commercialization of its targeted radiation therapy, and file for CE marking in Europe.
Advanced Medical Solutions said it will buy Raleigh Adhesive Coatings for £22m ($29m) in cash to strengthen its overall wound care business.
While Amgen said the Phase III GALACTIC-HF results for omecamtiv mecarbil did not meet its high expectations for the heart failure candidate, Cytokinetics sees a path to treating certain patients.